1. Agnarsson BA, Jonasson JG, Björnsdottir IB, Barkardottir RB, Egilsson V, Sigurdsson H (1998) Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat 47: 1212–1217
2. Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MRE, Giles GG, Hopper JL, Venter DJ (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 59: 2011–2017
3. Breast Cancer Trials Committee (1987) Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Lancet ii: 171–175
4. Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC (2001) Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clin Cancer Res 7: 1739–1742
5. Delozier T, Julien JP, Juret P, Veyret C, Couette JE, Graic Y, Ollivier JM, de Ranieri E (1986) Adjuvant tamoxifen in postmenopausal breast cancer- preliminary results of a randomized trial. Breast Cancer Res Treatment 7: 105–110